Objectives The aim of this study was to validate a standard- management of patients on NOACs undergoing dental extrac- ized pragmatic approach to manage new oral anticoagulants tion. Our pragmatic approach, omitting only a single morning (NOACs) in patients who undergo dental extractions. dose, can guide clinical practice. Both patients and physicians Materials and methods This prospective case-control study in should be aware of the increased delayed bleeding risk. patients undergoing dental extraction included 26 patients . . (mean age 76 years, 57% male) treated with dabigatran, Keywords Tooth extraction Anticoagulants New oral . . rivaroxaban, or apixaban and 26 matched controls. anticoagulants (NOACs) Interruption Bleeding Regardless of timing of extraction, drug regimen, or renal function, patients were instructed to skip only the dose on the morning of the procedure. A procedural bleeding score Introduction was recorded and early and delayed bleeding was assessed at day 1 and day 7. Bleeding events were compared with a Since the introduction of new oral anticoagulant drugs prospectively matched control group not taking any anti- (NOACs), the number of patients treated with this class of thrombotic drug. antithrombotics is steadily increasing. NOACs are indicated Results There was no difference in the procedural
Clinical Oral Investigations – Springer Journals
Published: Nov 28, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera